Risk and Severity of Hospital-AcquiredClostridium difficileInfection in Patients Taking Proton Pump Inhibitors-Reference-Cited by-同舟云学术

Risk and Severity of Hospital-AcquiredClostridium difficileInfection in Patients Taking Proton Pump Inhibitors

Published:2016-08-12 Issue:9 Volume:36 Page:986-993
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Lewis Paul O.¹,Litchfield John M.²,Tharp Jennifer L.¹,Garcia Rebecca M.³,Pourmorteza Mohsen⁴,Reddy Chakradhar M.²

Affiliation:

1. Department of Pharmacy; Johnson City Medical Center; Johnson City Tennessee

2. Division of Gastroenterology; East Tennessee State University James H. Quillen College of Medicine; Johnson City Tennessee

3. Department of Pharmacy; Medical University of South Carolina; Charleston South Carolina

4. Department of Internal Medicine; James H. Quillen College of Medicine; East Tennessee State University; Johnson City Tennessee

Publisher

Wiley

Subject

Pharmacology (medical)

Reference29 articles.

1. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection;Bavishi;Aliment Pharmacol Ther,2011

2. Centers for Disease Control and Prevention Antibiotic resistance threats in the United States 2013 http://www.cdc.gov/drugresistance/threat-report-2013/index.html

3. Economic healthcare costs of Clostridium difficile infection: a systemic review;Ghantoji;J Hosp Infect,2010

4. The economic impact of Clostridium difficile infection: a systematic review;Nanwa;Am J Gastroenterol,2015

5. FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs) http://www.fda.gov/Drugs/DrugSafety/ucm290510.htm

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of antacids for cisplatin-induced gastrointestinal symptoms in the treatment of lung cancer;Int. Journal of Clinical Pharmacology and Therapeutics;2023-06-01

2. Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides difficile Infection. Is There a Role of FMT in Primary Severe CDI?;Journal of Clinical Medicine;2021-12-13

3. Characteristics, Risk Factors, and Prevalence of Clostridioides difficile Among Hospitalized Patients in a Tertiary Care Hospital in Palestine;Infection and Drug Resistance;2021-11

4. Usual opioid dosing does not adversely affect the course of healthcare-associated Clostridioides difficile infection;Pain Management;2021-03

5. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study;Journal of Gastroenterology;2019-06-11